Gossamer Bio appoints Dr. John Quisel to its Board of Directors
– USA, CA – Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company, today announced the appointment of Dr.…
– USA, CA – Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company, today announced the appointment of Dr.…
– BELGIUM, Ghent – Agomab Therapeutics NV, a company developing differentiated programs with disease-modifying potential in fibrotic diseases, today announced the appointment of Dr.…
– USA, TX – AuraVax Therapeutics, Inc., a biotechnology company developing novel immunotherapies to prevent and treat respiratory viruses, today announced the appointments of Tom Finn and Dr.…
– USA, CA – Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced the appointment of Dr.…
– CANADA, Victoria – ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA), a leader in AI-driven biotherapeutic research and technology, today announced the appointment of Mitch Levine as Chairman of the Board of Directors, bringing a wealth of experience from the life sciences industry and financial strategy, particularly in Nasdaq market operations.…